BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells

Cell Growth and Differentiation

Volumn 7, Issue 6, 1996, Pages 711-715

  Vaughn, James P ^a   Davis, Penelope L ^a   Jarboe, Marcus D ^a   Huper, Gudrun ^a   Craig Evans, A ^a   Wiseman, Roger W ^b   Berchuck, Andrew ^a   Iglehart, J Dirk ^a   Futreal, P Andrew ^a   Marks, Jeffrey R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL CYCLE; DNA SYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; BREAST; BREAST NEOPLASMS; CELL LINE; DNA; DNA, NEOPLASM; EPITHELIAL CELLS; EPITHELIUM; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; OVARY; POINT MUTATION; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 10244246652     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ford, D., Easton, D., Bishop, D., Narod, S., and Goldgar, D. Risks of cancer in BRCA1-mutation carriers. Lancet, 343: 692-695, 1994.
2. Futreal, P. A., Liu, Q., Shaltuck-Eidens, D., Cochran, C. J., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J. R., Ballinger, D., Barrett, J. C., Skolnick, M., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
3. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA 1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439-443, 1995.
4. Shattuck-Eidens, D., McClure, M., Simard, J., Labrie, F., Narod, S., Couch, F., Hoskins, K., Weber, B., Castilla, L., Erdos, M., Brody, L., Friedman, L., Ostermeyer, E., Szabo, C., King, M. C., Jhanwar, S., Offit, K., Norton, L., Gilewski, T., Lubin, M., Osborne, M., Black, D., Boyd, M., Steel, M., Ingles, S., Haile, R., Lindblom, A., Olsson, H., Borg, A., Bishop, D. T., Solomon, E., Radice, P., Spatti, G., Gayther, S., Ponder, B., Warren, W., Stratton, M., Liu, Q., Fujimura, F., Lewis, C., Skolnick, M. H., and Goldgar, D. E. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. J. Am. Med. Assoc., 273: 535-541, 1995.
5. Cornelis, R. S., Neuhausen, S. L., Johansson, O., Arason, A., Kelsell, D., Ponder, B. A. J., Tonin, P., Hamann, U., Lindblom, A., Lalle, P., Longy, M., Olah, E., Scherneck, S., Bignon, Y-J., Sobol, H., Chang-Claude, J., Larsson, C., Spurr, N., Borg, A., Barkardottir, R. B., Narod, S., Devilee, P., and Breast Cancer Linkage Consortium. High allele loss rates at 17q12- q21 in breast and ovarian tumors from BRCA1-linked families. Genes Chromosomes & Cancer, 13: 203-210, 1995.
6. Havrilesky, L. J., Elbendary, A., Hurteau, J. A., Whitaker, R. S., Rodriguez, G. C., and Berchuck, A. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet. Gynecol., 85: 1007-1010, 1995.
7. Gudas, J. M., Nguyen, H., Li, T., and Cowan, K. H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55: 4561-4565, 1995.
8. Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444- 450, 1995.
9. Chen, Y., Chen, C., Riley, D. J., Allred, D. C., Chen, P., Von Hoff, D., Osborne, C. K., and Lee, W. H. Aberrant subcellular localization of BRCA1 in breast cancer. Science (Washington DC), 270: 789-791, 1995.
10. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shatter, D., Stone, S., Bayer, S., Wray, C., Borgden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P., Norris, F., Helvering, L., Morrison, P., Roseteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L, Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
11. Zeimet, A. G., Muller-Holzner, E., Marth, C., and Daxenbichler, G. Immunocytochemical versus biochemical receptor determination in normal and tumorous tissues of the female reproductive tract and breast. J. Steroid Biochem. Mol. Biol., 49: 365-372, 1994.
12. Hild-Petito, S., Stouffer, R. L., and Brenner, R. M. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology, 123: 2896-2905, 1988.
13. 1 to multiple cell cycles by lovastatin. Cancer Res., 57: 3602-3609, 1991.
14. Mosca, P. J., Dijkwel, P. A., and Hamlin, J. L. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol. Cell Biol., 12: 4375-4383, 1992.
15. Mosca, P. J., Lin, H. B., and Hamlin, J. L. Mimosine, a novel inhibitor of DMA replication, binds to a 50-kDa protein in Chinese hamster cells. Nucleic Acids Res., 23: 261-268, 1995.
16. Katagiri, Y., Emi, M., Ito, I., Kobayashi, K., Yoshimoto, M., Watanabe, S., Iwase, T., Kasumi, F., Miki, Y., Skolnick, M. H., and Nakamura, Y. Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum. Mutat., in press, 1996.
17. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G-Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of BRCA1 expression implies a role in the differentiation of the breast and other tissues. Nat. Genet, 11: 17-26, 1995.
18. Reich, N. C., and Levine, A. J. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (Lond.), 308: 199-201, 1984.
19. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
20. Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Artega, C. L., King, M., and Jensen, R. A. Growth retardation and tumour inhibition by BRCA1. Nat. Genet., 12: 298-302, 1996.
21. Band, V., and Sager, R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
22. Band, V., Zajchowski, D., Kulesa, V., and Sager, R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. USA, 87: 463-467, 1990.
23. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
24. 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth & Differ., 5: 1301-1307, 1994.